🍽️ bendroflumethiazide,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Blood Pressure Reduction: Bendroflumethiazide helps lower blood pressure by promoting the excretion of excess sodium and water through the kidneys, leading to decreased blood volume and reduced pressure within the blood vessels. By reducing blood pressure, bendroflumethiazide helps lower the risk of cardiovascular events such as heart attacks, strokes, and kidney damage associated with hypertension.

  2. Edema Management: Thiazide diuretics like bendroflumethiazide are effective in reducing edema by increasing urine production and reducing fluid accumulation in the body. This can be beneficial for individuals with conditions such as congestive heart failure, liver cirrhosis, and kidney disorders, where fluid retention may occur.

  3. Antihypertensive Effects: In addition to its diuretic effect, bendroflumethiazide may exert antihypertensive effects through other mechanisms, such as vasodilation and modulation of vascular tone. By promoting relaxation of the blood vessels, bendroflumethiazide helps improve blood flow and reduce peripheral resistance, contributing to its blood pressure-lowering effects.

  4. Potassium and Electrolyte Balance: While bendroflumethiazide promotes the excretion of sodium and water, it also increases the excretion of potassium. Therefore, patients taking bendroflumethiazide may be at risk of developing hypokalemia (low potassium levels), which can lead to symptoms such as muscle weakness, fatigue, and cardiac arrhythmias. Monitoring of potassium levels and supplementation may be necessary in some cases.

  5. Metabolic Effects: Thiazide diuretics like bendroflumethiazide can affect glucose and lipid metabolism. They may increase blood glucose levels and impair glucose tolerance, particularly in patients with diabetes or prediabetes. Additionally, thiazides may elevate serum lipid levels, including cholesterol and triglycerides, although the clinical significance of this effect remains debated.

  6. Renal Function: Bendroflumethiazide may have renal protective effects in certain populations, particularly individuals with chronic kidney disease and proteinuria (excess protein in the urine). By reducing blood pressure and intraglomerular pressure, bendroflumethiazide helps slow the progression of kidney damage and preserve renal function over time.

  7. Side Effects: Common side effects associated with bendroflumethiazide include dizziness, lightheadedness, headache, gastrointestinal upset, and electrolyte imbalances. Rare but serious adverse effects may include severe hypokalemia, hyponatremia (low sodium levels), hyperuricemia (elevated uric acid levels), and allergic reactions.

  8. Interactions: Bendroflumethiazide may interact with other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, lithium, and certain antidiabetic medications. These interactions can affect the efficacy and safety of bendroflumethiazide and may require dosage adjustments or monitoring.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of bendroflumethiazide,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Akkermansia muciniphila Reduces
species Bacteroides uniformis Reduces
species Bifidobacterium longum Reduces
species Escherichia coli Reduces
species Parabacteroides distasonis Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by bendroflumethiazide,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Akkermansiaceae family Decreases 👪 Source Study
Escherichia genus Decreases 👪 Source Study
Dorea genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Parabacteroides genus Decreases 👪 Source Study BMI, fat percent,blood pressure
Agathobacter genus Decreases 👪 Source Study
Bacteroides genus Decreases 👪 Source Study
Bifidobacterium genus Decreases 👪 Source Study
Clostridioides genus Decreases 👪 Source Study
Fusobacterium genus Decreases 👪 Source Study Periodontal disease, Lemierre syndrome, skin ulcers
Lacrimispora genus Decreases 👪 Source Study
Mediterraneibacter genus Decreases 👪 Source Study
Odoribacter genus Decreases 👪 Source Study
Phocaeicola genus Decreases 👪 Source Study
Streptococcus genus Decreases 👪 Source Study
Veillonella genus Decreases 👪 Source Study
Thomasclavelia genus Decreases 👪 Source Study
Akkermansia genus Decreases 📓 Source Study
Escherichia coli O25:H16 no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
Escherichia coli O145:H34 no rank Decreases 👶 Source Study
Escherichia coli O16:H48 no rank Decreases 👶 Source Study
unclassified Akkermansia no rank Decreases 👶 Source Study
Escherichia coli O141:H4 no rank Decreases 👶 Source Study
Escherichia coli O139:H1 no rank Decreases 👶 Source Study
Escherichia coli O80:H26 no rank Decreases 👶 Source Study
Escherichia coli O158:H23 no rank Decreases 👶 Source Study
Escherichia coli O84:H7 no rank Decreases 👶 Source Study
Escherichia coli O2:K1:H4 no rank Decreases 👶 Source Study
Escherichia coli O2:K1:H7 no rank Decreases 👶 Source Study
Escherichia coli O78:H51 no rank Decreases 👶 Source Study
Escherichia coli O18ac:H14 no rank Decreases 👶 Source Study
Escherichia coli O85:H1 no rank Decreases 👶 Source Study
Escherichia coli O7:H15 no rank Decreases 👶 Source Study
Escherichia coli O68:H12 no rank Decreases 👶 Source Study
Escherichia coli O55:H7 no rank Decreases 👶 Source Study
Escherichia coli O1:K1:H7 no rank Decreases 👶 Source Study
Escherichia coli O15:H12 no rank Decreases 👶 Source Study
Escherichia coli O170:H18 no rank Decreases 👶 Source Study
Escherichia coli O155:H21 no rank Decreases 👶 Source Study
Escherichia coli O19:H7 no rank Decreases 👶 Source Study
Escherichia coli O2:K1:H5 no rank Decreases 👶 Source Study
Escherichia coli O20:H12 no rank Decreases 👶 Source Study
Escherichia coli O111 serogroup Decreases 👶 Source Study
Escherichia coli O121 serogroup Decreases 👶 Source Study
Escherichia coli O155 serogroup Decreases 👶 Source Study
Escherichia coli O177 serogroup Decreases 👶 Source Study
Escherichia coli O26 serogroup Decreases 👶 Source Study
Escherichia coli O3 serogroup Decreases 👶 Source Study
Escherichia coli O5 serogroup Decreases 👶 Source Study
Escherichia coli O86 serogroup Decreases 👶 Source Study
Escherichia coli O91 serogroup Decreases 👶 Source Study
Escherichia coli O103 serogroup Decreases 👶 Source Study
Escherichia coli O78 serogroup Decreases 👶 Source Study
Escherichia coli O43 serogroup Decreases 👶 Source Study
Escherichia coli O119 serogroup Decreases 👶 Source Study
Escherichia coli O157 serogroup Decreases 👶 Source Study
Escherichia coli O145 serogroup Decreases 👶 Source Study
Escherichia coli O1:HNT serotype Decreases 👶 Source Study
Escherichia coli O10:K5(L):H4 serotype Decreases 👶 Source Study
Escherichia coli O103:H11 serotype Decreases 👶 Source Study
Escherichia coli O103:H25 serotype Decreases 👶 Source Study
Escherichia coli O104:H21 serotype Decreases 👶 Source Study
Escherichia coli O111:H11 serotype Decreases 👶 Source Study
Escherichia coli O111:H8 serotype Decreases 👶 Source Study
Escherichia coli O112ac:H19 serotype Decreases 👶 Source Study
Escherichia coli O114:H49 serotype Decreases 👶 Source Study
Escherichia coli O118:H16 serotype Decreases 👶 Source Study
Escherichia coli O121:H7 serotype Decreases 👶 Source Study
Escherichia coli O123:H11 serotype Decreases 👶 Source Study
Escherichia coli O127:H27 serotype Decreases 👶 Source Study
Escherichia coli O127:H6 serotype Decreases 👶 Source Study
Escherichia coli O128:H2 serotype Decreases 👶 Source Study
Escherichia coli O128ac:H12 serotype Decreases 👶 Source Study
Escherichia coli O145:H25 serotype Decreases 👶 Source Study
Escherichia coli O145:NM serotype Decreases 👶 Source Study
Escherichia coli O146:H21 serotype Decreases 👶 Source Study
Escherichia coli O153:H2 serotype Decreases 👶 Source Study
Escherichia coli O156:H25 serotype Decreases 👶 Source Study
Escherichia coli O157:H43 serotype Decreases 👶 Source Study
Escherichia coli O157:NM serotype Decreases 👶 Source Study
Escherichia coli O165:H25 serotype Decreases 👶 Source Study
Escherichia coli O174:H2 serotype Decreases 👶 Source Study
Escherichia coli O174:H21 serotype Decreases 👶 Source Study
Escherichia coli O174:H8 serotype Decreases 👶 Source Study
Escherichia coli O176:H45 serotype Decreases 👶 Source Study
Escherichia coli O177:NM serotype Decreases 👶 Source Study
Escherichia coli O26:H1 serotype Decreases 👶 Source Study
Escherichia coli O28ac:NM serotype Decreases 👶 Source Study
Escherichia coli O29:H4 serotype Decreases 👶 Source Study
Escherichia coli O32:H37 serotype Decreases 👶 Source Study
Escherichia coli O6:H16:CFA/II serotype Decreases 👶 Source Study
Escherichia coli O69:H11 serotype Decreases 👶 Source Study
Escherichia coli O78:H12 serotype Decreases 👶 Source Study
Escherichia coli O79:H7 serotype Decreases 👶 Source Study
Escherichia coli O81:NM serotype Decreases 👶 Source Study
Escherichia coli O86:H34 serotype Decreases 👶 Source Study
Escherichia coli O91:H14 serotype Decreases 👶 Source Study
Escherichia coli O91:NM serotype Decreases 👶 Source Study
Escherichia coli ONT:H33 serotype Decreases 👶 Source Study
Escherichia coli O100:H21 serotype Decreases 👶 Source Study
Escherichia coli O121:H19 serotype Decreases 👶 Source Study
Escherichia coli O157:H7 serotype Decreases 👶 Source Study bloody diarrhea
Escherichia coli O16:H6 serotype Decreases 👶 Source Study
Escherichia coli O89m:H9 serotype Decreases 👶 Source Study
Escherichia coli O111:H- serotype Decreases 👶 Source Study
Escherichia coli O113:H21 serotype Decreases 👶 Source Study
Escherichia coli H20 serotype Decreases 👶 Source Study
Escherichia coli O150:H6 serotype Decreases 👶 Source Study
Escherichia coli O111:NM serotype Decreases 👶 Source Study
Escherichia coli O112ab:H8 serotype Decreases 👶 Source Study
Escherichia coli O99:H6 serotype Decreases 👶 Source Study
Escherichia coli O26:H11 serotype Decreases 👶 Source Study
Escherichia coli O145:H28 serotype Decreases 👶 Source Study
Escherichia coli O126:H45 serotype Decreases 👶 Source Study
Escherichia coli O2:H6 serotype Decreases 👶 Source Study
Escherichia coli O7:H4 serotype Decreases 👶 Source Study
Escherichia coli O1:H42 serotype Decreases 👶 Source Study
Escherichia coli O25:NM serotype Decreases 👶 Source Study
Escherichia coli O25:H1 serotype Decreases 👶 Source Study
Escherichia coli O7:K1 serotype Decreases 👶 Source Study
Escherichia coli O125ac:K+:H10 serotype Decreases 👶 Source Study
Escherichia coli O6:K2:H1 serotype Decreases 👶 Source Study
Escherichia coli O152:H23 serotype Decreases 👶 Source Study
Escherichia coli O15:H18 serotype Decreases 👶 Source Study
Escherichia coli O39:NM serotype Decreases 👶 Source Study
Escherichia coli O44:H18 serotype Decreases 👶 Source Study
Escherichia coli O2:K2:H1 serotype Decreases 👶 Source Study
Escherichia coli O8:H8 serotype Decreases 👶 Source Study
Escherichia coli O89m:H10 serotype Decreases 👶 Source Study
Escherichia coli O10:H32 serotype Decreases 👶 Source Study
Escherichia coli O6:H16 serotype Decreases 👶 Source Study
Escherichia coli O157:H- serotype Decreases 👶 Source Study
Escherichia coli O45:H2 serotype Decreases 👶 Source Study
Escherichia coli O103:H2 serotype Decreases 👶 Source Study
Escherichia coli O167:H26 serotype Decreases 👶 Source Study
Escherichia coli O104:H4 serotype Decreases 👶 Source Study
Escherichia coli O83:H1 serotype Decreases 👶 Source Study
Escherichia coli O9:H10 serotype Decreases 👶 Source Study
Escherichia coli O78:H4 serotype Decreases 👶 Source Study
Escherichia coli O139:H28 serotype Decreases 👶 Source Study
Mediterraneibacter gnavus species Decreases 📓 Source Study
Escherichia coli species Decreases 📓 Source Study Diarrheal disease in children and travelers, Foodborne diarrhea outbreaks, hemorrhagic colitis, hemolytic-uremic syndrome
Bacteroides fragilis species Decreases 📓 Source Study H02076 Bacteroides infection
Streptococcus parasanguinis species Decreases 📓 Source Study
Lacrimispora saccharolytica species Decreases 📓 Source Study
Dorea formicigenerans species Decreases 📓 Source Study
Akkermansia massiliensis species Decreases 👶 Source Study
Candidatus Akkermansia intestinavium species Decreases 👶 Source Study
Agathobacter rectalis species Decreases 📓 Source Study
Phocaeicola vulgatus species Decreases 📓 Source Study
Parabacteroides distasonis species Decreases 📓 Source Study
Bacteroides uniformis species Decreases 📓 Source Study Infectious bacteria
Thomasclavelia ramosa species Decreases 📓 Source Study
Parabacteroides merdae species Decreases 📓 Source Study Infectious bacteria
Fusobacterium nucleatum species Decreases 📓 Source Study Infectious bacteria
Roseburia hominis species Decreases 📓 Source Study
Bifidobacterium longum species Decreases 📓 Source Study
Clostridioides difficile species Decreases 📓 Source Study Colitis
Veillonella parvula species Decreases 📓 Source Study
Streptococcus salivarius species Decreases 📓 Source Study Infectious bacteria
Akkermansia muciniphila species Decreases 📓 Source Study High Levels linked to long-lived individuals
Odoribacter splanchnicus species Decreases 📓 Source Study
Akkermansia glycaniphila species Decreases 👶 Source Study
Bacteroides xylanisolvens species Decreases 📓 Source Study
Bifidobacterium longum subsp. longum subspecies Decreases 👶 Source Study
Bifidobacterium longum subsp. infantis subspecies Decreases 👶 Source Study
Bifidobacterium longum subsp. suis subspecies Decreases 👶 Source Study
Fusobacterium nucleatum subsp. nucleatum subspecies Decreases 👶 Source Study
Bifidobacterium longum subsp. suillum subspecies Decreases 👶 Source Study

Impact of bendroflumethiazide,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.3 0.3 0
ADHD 2.9 0.3 8.67
Age-Related Macular Degeneration and Glaucoma 1.1 0.4 1.75
Allergic Rhinitis (Hay Fever) 3 1.4 1.14
Allergies 3.7 0.9 3.11
Allergy to milk products 0.8 1.6 -1
Alopecia (Hair Loss) 0.8 0.8
Alzheimer's disease 3.5 3.7 -0.06
Amyotrophic lateral sclerosis (ALS) Motor Neuron 2.3 0.5 3.6
Ankylosing spondylitis 3 1.1 1.73
Anorexia Nervosa 1 2.1 -1.1
Antiphospholipid syndrome (APS) 0.7 0.7
Asthma 3.8 1.8 1.11
Atherosclerosis 1.7 0.9 0.89
Atrial fibrillation 2.9 1.9 0.53
Autism 5.2 5.6 -0.08
Autoimmune Disease 1.2 0.8 0.5
Barrett esophagus cancer 0.6 0.3 1
benign prostatic hyperplasia 0.6 0.3 1
Biofilm 1.9 1.9
Bipolar Disorder 1.3 0.8 0.63
Brain Trauma 0.6 1.1 -0.83
Breast Cancer 0.5 0.5
Cancer (General) 0.9 0.4 1.25
Carcinoma 3.1 1.9 0.63
Celiac Disease 2.3 2.2 0.05
Cerebral Palsy 1.2 0.8 0.5
Chronic Fatigue Syndrome 2.5 2.9 -0.16
Chronic Kidney Disease 2.7 0.9 2
Chronic Lyme 0.1 0.8 -7
Chronic Obstructive Pulmonary Disease (COPD) 1.7 1.4 0.21
Chronic Urticaria (Hives) 1.6 0.5 2.2
Coagulation / Micro clot triggering bacteria 1.8 0.8 1.25
Cognitive Function 2.4 1.4 0.71
Colorectal Cancer 6.1 2.1 1.9
Constipation 1.1 0.5 1.2
Coronary artery disease 2.1 2.1 0
COVID-19 4.3 4.1 0.05
Crohn's Disease 6 3.5 0.71
Cushing's Syndrome (hypercortisolism) 0.6 -0.6
cystic fibrosis 1 1.1 -0.1
d-lactic acidosis (one form of brain fog) 0.4 0.4
deep vein thrombosis 2.1 1.1 0.91
Denture Wearers Oral Shifts 0.5 0.5
Depression 6.1 4.8 0.27
Dermatomyositis 0.3 0.3 0
Eczema 2 1.1 0.82
Endometriosis 2.9 1.6 0.81
Eosinophilic Esophagitis 0.3 0.6 -1
Epilepsy 2.6 1.2 1.17
erectile dysfunction 1.8 0.3 5
Fibromyalgia 2.1 0.7 2
Functional constipation / chronic idiopathic constipation 3.4 2 0.7
gallstone disease (gsd) 3.3 1.1 2
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 1.4 0.3 3.67
Generalized anxiety disorder 2.4 1.5 0.6
Glioblastoma 0.3 -0.3
Gout 0.6 0 0
Graves' disease 1.3 2.3 -0.77
Gulf War Syndrome 0.3 0.8 -1.67
Halitosis 1.2 0.3 3
Hashimoto's thyroiditis 2.7 0.6 3.5
Heart Failure 2.7 1.1 1.45
hemorrhagic stroke 1.3 1.3
Hidradenitis Suppurativa 0.9 0.3 2
High Histamine/low DAO 1 0.3 2.33
hypercholesterolemia (High Cholesterol) 0.7 0 0
hyperglycemia 1.7 1.1 0.55
Hyperlipidemia (High Blood Fats) 0.3 0.3
hypertension (High Blood Pressure 2.7 2.3 0.17
Hypothyroidism 0 0.3 0
Hypoxia 2.6 0.3 7.67
IgA nephropathy (IgAN) 1.3 1.8 -0.38
Inflammatory Bowel Disease 4.6 4 0.15
Insomnia 1.5 1.8 -0.2
Intelligence 0.9 0.9
Intracranial aneurysms 1 0.3 2.33
Irritable Bowel Syndrome 4.5 2.6 0.73
ischemic stroke 2.1 1.7 0.24
Liver Cirrhosis 5.2 3.7 0.41
Long COVID 4 3.1 0.29
Low bone mineral density 0.5 -0.5
Lung Cancer 0.6 0.6 0
Lymphoma 0.6 0.6
Mast Cell Issues / mastitis 1 0.3 2.33
ME/CFS with IBS 0.3 0.9 -2
ME/CFS without IBS 0.8 1.7 -1.13
membranous nephropathy 0.3 0.3
Menopause 0.3 0.6 -1
Metabolic Syndrome 5 4.7 0.06
Mood Disorders 4.9 3.5 0.4
multiple chemical sensitivity [MCS] 0.6 0.6
Multiple Sclerosis 3.2 3.1 0.03
Multiple system atrophy (MSA) 0.5 0.3 0.67
myasthenia gravis 0.9 0.5 0.8
neuropathic pain 1.8 -1.8
Neuropathy (all types) 0.3 1.6 -4.33
neuropsychiatric disorders (PANDAS, PANS) 1 1
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 3.5 1.8 0.94
NonCeliac Gluten Sensitivity 0.6 0.6 0
Obesity 6 5.2 0.15
obsessive-compulsive disorder 3.2 2.6 0.23
Osteoarthritis 2 0.9 1.22
Osteoporosis 1.7 1.2 0.42
pancreatic cancer 0.7 0.3 1.33
Parkinson's Disease 4.4 4.6 -0.05
Polycystic ovary syndrome 4.2 1.7 1.47
Postural orthostatic tachycardia syndrome 0.3 -0.3
Premenstrual dysphoric disorder 0.3 0.4 -0.33
primary biliary cholangitis 1.2 0.7 0.71
Primary sclerosing cholangitis 2 1.1 0.82
Psoriasis 2.1 1.8 0.17
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 4 3.3 0.21
Rosacea 0.3 0.8 -1.67
Schizophrenia 2.5 1.9 0.32
scoliosis 0.4 0.4
Sjögren syndrome 1.9 2 -0.05
Sleep Apnea 1.2 0.8 0.5
Slow gastric motility / Gastroparesis 1 0.3 2.33
Small Intestinal Bacterial Overgrowth (SIBO) 1.6 0.1 15
Stress / posttraumatic stress disorder 2.9 1.6 0.81
Systemic Lupus Erythematosus 3.4 1.4 1.43
Tic Disorder 0.8 0.9 -0.13
Tourette syndrome 0.9 0.3 2
Type 1 Diabetes 2.2 2.1 0.05
Type 2 Diabetes 5.8 4.7 0.23
Ulcerative colitis 4.1 2.9 0.41
Unhealthy Ageing 3.1 1.9 0.63
Vitiligo 1.7 0.7 1.43

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]